Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells.
Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells.
复制标题
DOI:
10.1002/adma.201103550
复制
发表时间:
2012-07-24
影响因子:
29.4
通讯作者:
Lapotko, Dmitri O.
中科院分区:
文献类型:
--
作者:
Lukianova-Hleb, Ekaterina Y.;Ren, Xiaoyang;Zasadzinski, Joseph A.;Wu, Xiangwei;Lapotko, Dmitri O.
Oral cavity squamous cell carcinoma (OCSCC) is one of the most prevalent malignancies affecting patients worldwide.[1] Advanced OCSCCs are at high risk for local recurrence and are associated with poor prognosis.[2] The major reasons for this are 1) incomplete removal of cancer cells by surgery, especially when complicated by micro metastasis and colocalization of cancer cells with functionally or cosmetically important structures; 2) multidrug resistance of cancer cells, and 3) acute and long-term toxicities of radio-and chemotherapies. Therefore, new treatment strategies are needed to provide cell level selectivity of cancer treatment and high efficacy against drug-resistant cells for OCSCC and other superficial cancers.By themselves, NPs [3] can destroy cancer cells via hyperthermia by converting optical, radiofrequency and/or magnetic energy into local heating.[4, 5, 6] However, such direct heating methods require significant NP loading, thus limiting selectivity due to the diffusive heating of surrounding tissue. A superior approach is to use NPs to generate plasmonic nanobubbles (PNB), transient vapor nanobubbles generated by short laser pulses that superheat gold NPs.[7, 8] The temporally and spatially controlled initiation and collapse of PNBs creates local optical and mechanical effects that can enable imaging,[8] intracellular molecular targeting,[9] localized drug or gene delivery,[10] and selective elimination of cells for therapeutics, theranostics and microsurgery.[11, 12] In addition, the optical and acoustical properties of PNBs provide a mechanism for real-time guidance of their therapeutic
登录
查看更多内容
DOI:
10.2217/nnm.10.133
发表时间:
2011-04
期刊:
Nanomedicine (London, England)
影响因子:
--
作者:
Huang HC;Yang Y;Nanda A;Koria P;Rege K
通讯作者:
Rege K
影响因子:
10.8
作者:
Anderson, Lindsey J. E.;Hansen, Eric;Lukianova-Hleb, Ekaterina Y.;Hafner, Jason H.;Lapotko, Dmitri O.
通讯作者:
Lapotko, Dmitri O.
影响因子:
14
作者:
Lukianova-Hleb, Ekaterina Y.;Belyanin, Andrey;Kashinath, Shruti;Wu, Xiangwei;Lapotko, Dmitri O.
通讯作者:
Lapotko, Dmitri O.
影响因子:
5.5
作者:
Lapotko, Dmitri O.;Lukianova-Hleb, Ekaterina Y.;Oraevsky, Alexander A.
通讯作者:
Oraevsky, Alexander A.
影响因子:
254.7
作者:
Jemal, Ahmedin;Siegel, Rebecca;Ward, Elizabeth
通讯作者:
Ward, Elizabeth